Formed in 2006 the BioBohemia brought together perspective scientists into a business structure committed to the development of novel products and procedures for applications in anti-cancer therapy. From the beginning of 2008 the BioBohemia places emphasis on R&D of cancer vaccines. 

Basic directions of activity
• R&D of antigens intended to anti-cancer vaccination
• R&D of antigens intended to antiangiogenic anti-cancer vaccine (against all solid tumors)
• Production qualified antigens for cancer vaccines
• Quality control procedures for antigens intended for anti-cancer vaccination
• Research in field of personalized polyvalent cancer vaccines 

Roadmap plan
2006-2011 R&D of antigens for cancer vaccines.
2012-2014 Manufacture of cancer vaccines and clinical trials.  
2015- ...     Manufacture and  worldwide distribution of efficient, cheap and safe cancer vaccines. Vaccination of all people around the world.